COGT
Price
$6.80
Change
+$0.81 (+13.52%)
Updated
Jun 6 closing price
Capitalization
774.22M
64 days until earnings call
PBYI
Price
$3.72
Change
+$0.07 (+1.92%)
Updated
Jun 6 closing price
Capitalization
181.18M
52 days until earnings call
Interact to see
Advertisement

COGT vs PBYI

Header iconCOGT vs PBYI Comparison
Open Charts COGT vs PBYIBanner chart's image
Cogent Biosciences
Price$6.80
Change+$0.81 (+13.52%)
Volume$2.72M
Capitalization774.22M
Puma Biotechnology
Price$3.72
Change+$0.07 (+1.92%)
Volume$513.42K
Capitalization181.18M
COGT vs PBYI Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. PBYI commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and PBYI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (COGT: $4.88 vs. PBYI: $3.37)
Brand notoriety: COGT and PBYI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 76% vs. PBYI: 65%
Market capitalization -- COGT: $680.86M vs. PBYI: $181.18M
COGT [@Biotechnology] is valued at $680.86M. PBYI’s [@Biotechnology] market capitalization is $181.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whilePBYI’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • PBYI’s FA Score: 1 green, 4 red.
According to our system of comparison, PBYI is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 3 TA indicator(s) are bullish while PBYI’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 3 bullish, 3 bearish.
  • PBYI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PBYI is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -2.01% price change this week, while PBYI (@Biotechnology) price change was +0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

PBYI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($774M) has a higher market cap than PBYI($181M). PBYI YTD gains are higher at: 10.492 vs. COGT (-37.436). PBYI has higher annual earnings (EBITDA): 48.1M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. PBYI (101M). COGT has less debt than PBYI: COGT (17.5M) vs PBYI (74.1M). PBYI has higher revenues than COGT: PBYI (230M) vs COGT (0).
COGTPBYICOGT / PBYI
Capitalization774M181M428%
EBITDA-271.59M48.1M-565%
Gain YTD-37.43610.492-357%
P/E RatioN/A4.68-
Revenue0230M-
Total Cash287M101M284%
Total Debt17.5M74.1M24%
FUNDAMENTALS RATINGS
COGT vs PBYI: Fundamental Ratings
COGT
PBYI
OUTLOOK RATING
1..100
1719
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
9924
PRICE GROWTH RATING
1..100
6544
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5023

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBYI's Valuation (39) in the Biotechnology industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that PBYI’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (76) in the Miscellaneous industry is in the same range as PBYI (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to PBYI’s over the last 12 months.

PBYI's SMR Rating (24) in the Biotechnology industry is significantly better than the same rating for COGT (99) in the Miscellaneous industry. This means that PBYI’s stock grew significantly faster than COGT’s over the last 12 months.

PBYI's Price Growth Rating (44) in the Biotechnology industry is in the same range as COGT (65) in the Miscellaneous industry. This means that PBYI’s stock grew similarly to COGT’s over the last 12 months.

PBYI's P/E Growth Rating (98) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that PBYI’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTPBYI
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
82%
Advances
ODDS (%)
Bullish Trend 20 days ago
83%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
N/A
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-0.23%
IDYA - COGT
54%
Loosely correlated
+0.72%
XNCR - COGT
53%
Loosely correlated
-2.58%
RARE - COGT
52%
Loosely correlated
-2.08%
More

PBYI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with RGNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBYI
1D Price
Change %
PBYI100%
-2.03%
RGNX - PBYI
38%
Loosely correlated
-5.84%
COGT - PBYI
38%
Loosely correlated
N/A
AURA - PBYI
37%
Loosely correlated
+0.17%
VYGR - PBYI
36%
Loosely correlated
-3.19%
ABOS - PBYI
35%
Loosely correlated
N/A
More